Clostridium clinical trials at UCSD

1 in progress, 0 open to eligible people

Optimal Treatment for Recurrent Clostridium Difficile
Sorry, in progress, not accepting new patients
The purpose of this study is to determine whether fidaxomicin and vancomycin followed by taper and pulse vancomycin treatment are superior to standard vancomycin treatment for the treatment of recurrent Clostridium difficile infection.
San Diego, California and other locations

Last updated: August 21, 2024